Jonathan Soriano
About Jonathan Soriano
Jonathan Soriano is a Manager of Program Management at Tessera Therapeutics, where he has worked since 2021. He has a background in protein therapeutics and has held various scientific roles at organizations including Cue Biopharma and MassBiologics.
Current Role at Tessera Therapeutics
Jonathan Soriano serves as the Manager of Program Management at Tessera Therapeutics since 2021. In this role, he oversees various projects and initiatives within the organization, contributing to the development of innovative therapeutic solutions. His position involves coordinating cross-functional teams and ensuring that program objectives align with the company's strategic goals.
Previous Experience at Cue Biopharma
Before joining Tessera Therapeutics, Jonathan Soriano worked at Cue Biopharma, formerly known as ImaGEN Biopharma, from 2016 to 2021. He held two positions during his tenure: Associate Scientist and later Scientist in Protein Therapeutics. His work focused on developing protein-based therapies, contributing to advancements in the field during his three years in Cambridge, MA.
Research Background at MassBiologics
Jonathan Soriano's research career began at MassBiologics, where he worked as a Research Associate from 2012 to 2015. He was involved in the Nonhuman Primate Reagent Resource (NHPRR) project, contributing to the development of reagents for nonhuman primate studies. His experience in this role provided him with a strong foundation in biological research methodologies.
Educational Qualifications
Jonathan Soriano earned a Master of Science in Medical Sciences from Boston University School of Medicine, completing his studies from 2010 to 2012. Prior to this, he obtained a Bachelor of Science in Biology from Tufts University, where he studied from 2006 to 2010. His educational background has equipped him with a solid understanding of biological sciences and medical research.
Early Research Experience
Jonathan Soriano began his research career as an Undergraduate Researcher at Tufts University from 2009 to 2010. He then transitioned to a Graduate Researcher role at Massachusetts General Hospital in the Plastic Surgery & Orthopedics department from 2011 to 2012. These early experiences laid the groundwork for his future work in the biopharmaceutical industry.